BlackRock Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$200K Hold
2,052
﹤0.01% 2652
2016
Q3
$193K Hold
2,052
﹤0.01% 2643
2016
Q2
$221K Hold
2,052
﹤0.01% 2547
2016
Q1
$246K Hold
2,052
﹤0.01% 2505
2015
Q4
$244K Hold
2,052
﹤0.01% 2462
2015
Q3
$350K Hold
2,052
﹤0.01% 2340
2015
Q2
$398K Buy
2,052
+1,723
+524% +$320K ﹤0.01% 2348
2015
Q1
$49K Buy
+329
New +$50.1K ﹤0.01% 2773
2013
Q4
Sell
-2,470
Closed -$277K 2810
2013
Q3
$277K Buy
+2,470
New +$280K ﹤0.01% 2398

Other funds holding SRGA

BlackRock Group's SRGA Position: Q4 2016 in Review

BlackRock Group held its Surgalign Holdings, Inc. Common Stock (SRGA) position steady in Q4 2016 at 2,052 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

BlackRock Group first reported a position in SRGA in Q3 2013 and has held it in 9 quarters since. The position peaked at $398K in Q2 2015. 108 funds tracked by Wall St. Rank hold SRGA as of Q4 2016.

  • BlackRock Group held 2,052 shares of Surgalign Holdings, Inc. Common Stock worth $200K as of Q4 2016.
  • BlackRock Group left its Surgalign Holdings, Inc. Common Stock share count unchanged in Q4 2016.
  • Surgalign Holdings, Inc. Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2652 holding.
  • BlackRock Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2013 and has held it in 9 quarters since.
  • BlackRock Group's Surgalign Holdings, Inc. Common Stock position peaked at $398K in Q2 2015.
  • 108 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.